Table 2.
10 Fr (n = 115) |
11.5 Fr (n = 119) | P value | |
---|---|---|---|
Technical success | 99.1% (114/115) | 97.4% (116/119) | 0.37 |
Baseline bilirubin (mg/dL) | 10.7 ± 6.8 | 12.8 ± 7.6 | 0.03 |
Bilirubin decrease (mg/dL) | 8.7 ± 6.1* | 10.6 ± 6.9* | 0.077* |
Days to stent failure | 149 | 258 | 0.16 |
Stent-related hosp. days (Mean) | 1.6 ± 3.5 | 1.9 ± 3.8 | 0.50 |
Stent-related interventions (mean) | 0.74 ± 1.5 | 0.82 ± 1.5 | 0.66 |
Median patient survival days | 151 | 206 | 0.20 |
*After adjusting for difference in baseline bilirubin.